Skip to main content

Rigel Pharmaceuticals Inc 10-Q for FY2025 Q3

Rigel Pharmaceuticals Inc (RIGL)

10-Q 2025-11-04 For: 2025-09-30
View Original
Added on April 06, 2026

About this 10-Q

Rigel Pharmaceuticals Inc filed this 10-Q on November 4, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).

Headline figures

Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$69.46M
up 25.6% from $55.31M a year earlier
Net income
$27.9M
up 124.6% from net income of $12.42M a year earlier
Diluted EPS
$1.46
up 108.6% from $0.70 a year earlier